Glaucoma surgery checked 5 years later: does it hold up?

NCT ID NCT07480343

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Iantrek, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This study follows 250 people with open-angle glaucoma who had a new type of surgery called CycloPen, which aims to improve fluid drainage from the eye. Researchers will measure eye pressure at 3, 4, and 5 years after surgery to see if the benefits last. The goal is to understand how well this procedure controls glaucoma over the long term.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that the CycloPen surgery provides lasting pressure control for glaucoma patients, potentially reducing the need for daily eye drops.
What could go wrong: This is an observational follow-up, not a new treatment test. It only includes patients who already did well initially, so results may not apply to everyone with glaucoma.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA (OAG) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPEN-ANGLE GLAUCOMA (OAG)

Contacts and locations

Locations

CREST-XT Site 01

Fort Washington, Pennsylvania, 19034, United States
CREST-XT Site 03

Cape Coral, Florida, 33904, United States
CREST-XT Site 04

Crossville, Tennessee, 38555, United States
CREST-XT Site 05

Newport Beach, California, 92663, United States
CREST-XT Site 07

Atlanta, Georgia, 30342, United States
CREST-XT Site 10

DeLand, Florida, 32720, United States
CREST-XT Site 11

Salt Lake City, Utah, 84132, United States
CREST-XT Site 12

Chevy Chase, Maryland, 20815, United States
CREST-XT Site 13

Rockville, Maryland, 20852, United States
CREST-XT Site 16

Las Vegas, Nevada, 89145, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.